Agomab Spain (previously Origo Biopharma) is a biotechnology company founded by entrepreneurs with extensive experience in pharmaceutical discovery and development. Specializing in the research and development of immunotherapeutic products focused on treating health disorders related to TGF-β signaling dysfunction, including cancer and fibrosis. Focused on early discovery and development of novel drugs with high unmet medical needs.
Business areas:
Pharmaceutical industry, drug discovery, drug development, R&D, immunomodulation, immuno-oncology, Cancer, Fibrosis.
Business lines:
Drug discovery, Early drug development.